Thursday, November 19, 2026
The top medical stories of the day, as they ran.
Morning edition
9 stories
- 1U.S. loses measles elimination status after 26 yearsInfectious disease · 5 outlets
- 2White House withdraws Heidi Overton’s FDA nominationDrugs and FDA · 12 outlets
- 3Hims & Hers launches five compounded peptide and longevity treatmentsDrugs and FDA · 3 outlets
- 4FDA approves adrabetadex for infantile-onset Niemann-Pick diseaseDrugs and FDA · 2 outlets
- 5Diranersen showed continued benefit in Alzheimer’s trial extension at 2 yearsResearch · 2 outlets
- 6Pfizer licenses three in vivo CAR-T therapies from StarnaIndustry · 3 outlets
- 7Sanders plans to make Medicare for All a Democratic priorityHealth policy · 2 outlets
- 8FDA cites modest benefit and safety risks in rejecting Summit’s lung cancer drugDrugs and FDA · 2 outlets
- 9CDC reports drug-resistant typhoid cases in travelers from SenegalInfectious disease · 1 outlet
Evening edition
12 stories
- 1FDA approves Infilbray for neurological symptoms of type 3 Gaucher diseaseDrugs and FDA · 5 outlets
- 2U.S. loses measles elimination status after 26 yearsInfectious disease · 4 outlets
- 3White House withdraws Heidi Overton’s FDA nominationDrugs and FDA · 5 outlets
- 4FDA approves Regeneron’s first siRNA therapy for myasthenia gravisDrugs and FDA · 3 outlets
- 5Pennsylvania reports eighth measles-related deathOutbreaks · 2 outlets
- 6Study links blood tau marker with CTE in former football playersResearch · 3 outlets
- 7Democrats back plan to expand Medicare coverageMedicare and Medicaid · 2 outlets
- 8Sanofi Pompe drug shortage continues to disrupt patient infusionsDrugs and FDA · 1 outlet
- 9Congressional commission warns China could gain an edge in biopharmaHealth policy · 2 outlets
- 10Grand Strand recalls four breakfast biscuit products over possible Listeria contaminationRecalls · 1 outlet
- 11ACC statement outlines strategies for earlier lipid-lowering treatmentHeart health · 1 outlet
- 12FDA cites modest benefit and safety risks in rejecting Summit’s lung cancer drugDrugs and FDA · 2 outlets